Alkem Laboratories informs about quarterly statement on investor complaints

11 Jan 2017 Evaluate

Alkem Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5461.00 -38.75 (-0.70%)
30-Dec-2025 10:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.00
Dr. Reddys Lab 1270.20
Cipla 1488.45
Zydus Lifesciences 901.80
Lupin 2089.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×